1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Orthopedics Market Trends
  5. > Japan Orthobiologics Market Outlook to 2021

Japan Orthobiologics Market Outlook to 2021

  • September 2015
  • -
  • Global Data
  • -
  • 59 pages

Japan Orthobiologics Market Outlook to 2021

Summary

GlobalData’s new report, "Japan Orthobiologics Market Outlook to 2021", provides key market data on the Japan Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Orthobiologics market.
- Global corporate-level profiles of key companies operating within the Japan Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Japan Orthobiologics Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Orthobiologics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Orthobiologics Market, Japan 8
3.1 Orthobiologics Market, Japan, Revenue ($m), 2007-2014 8
3.2 Orthobiologics Market, Japan, Revenue ($m), 2014-2021 10
3.2.1 Bone Grafts and Substitutes Market, Japan, Revenue ($m), by Segment, 2007-2014 12
3.2.2 Bone Growth Stimulators Market, Japan, Revenue ($m), by Segment, 2007-2014 14
3.2.3 Viscosupplementation Market, Japan, Revenue ($m), by Segment, 2007-2014 16
3.2.4 Bone Grafts and Substitutes Market, Japan, Revenue ($m), by Segment, 2014-2021 18
3.2.5 Bone Growth Stimulators Market, Japan, Revenue ($m), by Segment, 2014-2021 20
3.2.6 Viscosupplementation Market, Japan, Revenue ($m), by Segment, 2014-2021 22
3.3 Orthobiologics Market, Japan, Volume (Units), 2007-2014 24
3.4 Orthobiologics Market, Japan, Volume (Units), 2014-2021 26
3.4.1 Bone Grafts and Substitutes Market, Japan, Volume (Units), by Segment, 2007-2014 28
3.4.2 Bone Growth Stimulators Market, Japan, Volume (Units), by Segment, 2007-2014 30
3.4.3 Viscosupplementation Market, Japan, Volume (Units), by Segment, 2007-2014 32
3.4.4 Bone Grafts and Substitutes Market, Japan, Volume (Units), by Segment, 2014-2021 34
3.4.5 Bone Growth Stimulators Market, Japan, Volume (Units), by Segment, 2014-2021 36
3.4.6 Viscosupplementation Market, Japan, Volume (Units), by Segment, 2014-2021 38
3.5 Orthobiologics Market, Japan, Average Price ($), 2007-2021 40
3.6 Orthobiologics Market, Japan, Distribution Share by Revenue ($m), 2013-2014 42
3.7 Orthobiologics Market, Japan, Company Share by Revenue ($m), 2014 43
4 Overview of Key Companies in Japan, Orthobiologics Market 45
4.1 Seikagaku Corporation 45
4.1.1 Company Overview 45
4.2 DePuy Companies 45
4.2.1 Company Overview 45
4.3 Medtronic plc 45
4.3.1 Company Overview 45
4.4 Sanofi 46
4.4.1 Company Overview 46
4.5 Stryker Corporation 46
4.5.1 Company Overview 46
4.6 Arthrex, Inc. 46
4.6.1 Company Overview 46
5 Orthobiologics Market Pipeline Products 47
6 Appendix 51
6.1 Research Methodology 52
6.1.1 Coverage 52
6.1.2 Secondary Research 52
6.1.3 Primary Research 53
6.1.4 Market Modeling and Forecasting 54
6.1.5 Company Share Analysis 57
6.1.6 Distribution Share Analysis 58
6.2 Expert Panel 59
6.3 GlobalData Consulting 59
6.4 Contact Us 59
6.5 Disclaimer 59

1.1 List of Tables
Table 1: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 9
Table 2: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Table 3: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 13
Table 4: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 15
Table 5: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 17
Table 6: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 19
Table 7: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 21
Table 8: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Table 9: Orthobiologics Market, Japan, Volume (Units), Historic, 2007-2014 25
Table 10: Orthobiologics Market, Japan, Volume (Units), Forecast, 2014-2021 27
Table 11: Bone Grafts and Substitutes Market, Japan, Volume (Units), Historic, 2007-2014 29
Table 12: Bone Growth Stimulators Market, Japan, Volume (Units), Historic, 2007-2014 31
Table 13: Viscosupplementation Market, Japan, Volume (Units), Historic, 2007-2014 33
Table 14: Bone Grafts and Substitutes Market, Japan, Volume (Units), Forecast, 2014-2021 35
Table 15: Bone Growth Stimulators Market, Japan, Volume (Units), Forecast, 2014-2021 37
Table 16: Viscosupplementation Market, Japan, Volume (Units), Forecast, 2014-2021 39
Table 17: Orthobiologics Market, Japan, Average Price ($) Historic, 2007-2014 40
Table 18: Orthobiologics Market, Japan, Average Price ($), Forecast, 2014-2021 41
Table 19: Orthobiologics Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014 42
Table 20: Orthobiologics Market, Japan, Company Share by Revenue ($m), USD Constant, 2014 44
Table 21: Orthobiologics Market Pipeline Products 47
Table 22: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 54

1.2 List of Figures
Figure 1: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 8
Figure 2: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Figure 3: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 12
Figure 4: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 14
Figure 5: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014 16
Figure 6: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 18
Figure 7: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 20
Figure 8: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021 22
Figure 9: Orthobiologics Market, Japan, Volume (Units), Historic, 2007-2014 24
Figure 10: Orthobiologics Market, Japan, Volume (Units), Forecast, 2014-2021 26
Figure 11: Bone Grafts and Substitutes Market, Japan, Volume (Units), Historic, 2007-2014 28
Figure 12: Bone Growth Stimulators Market, Japan, Volume (Units), Historic, 2007-2014 30
Figure 13: Viscosupplementation Market, Japan, Volume (Units), Historic, 2007-2014 32
Figure 14: Bone Grafts and Substitutes Market, Japan, Volume (Units), Forecast, 2014-2021 34
Figure 15: Bone Growth Stimulators Market, Japan, Volume (Units), Forecast, 2014-2021 36
Figure 16: Viscosupplementation Market, Japan, Volume (Units), Forecast, 2014-2021 38
Figure 17: Orthobiologics Market, Japan, Company Share (%) 2014 43
Figure 18: GlobalData Epidemiology-Based Forecasting Model 56
Figure 19: GlobalData Capital Equipment-Based Forecasting Model 57
Figure 20: Primary Interviews by Participant Type (%) 58

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Norway Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Norway Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

  • $ 5995
  • Industry report
  • September 2016
  • by Global Data

Norway Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others ...

Turkey Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Turkey Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

  • $ 5995
  • Industry report
  • September 2016
  • by Global Data

Turkey Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others ...

Israel Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Israel Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

  • $ 5995
  • Industry report
  • September 2016
  • by Global Data

Israel Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.